MNG671
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- INTERFERON_ALPHA_RESPONSE+0.374
- MITOTIC_SPINDLE+0.351
- UV_RESPONSE_DN+0.317
- ADIPOGENESIS+0.306
- WNT_BETA_CATENIN_SIGNALING+0.304
- PEROXISOME+0.288
- PI3K_AKT_MTOR_SIGNALING+0.265
- TGF_BETA_SIGNALING+0.216
- INTERFERON_GAMMA_RESPONSE+0.212
- APICAL_SURFACE+0.194
Top 10 suppressed
- TNFA_SIGNALING_VIA_NFKB-0.421
- PANCREAS_BETA_CELLS-0.387
- SPERMATOGENESIS-0.301
- ANGIOGENESIS-0.294
- E2F_TARGETS-0.238
- G2M_CHECKPOINT-0.182
- P53_PATHWAY-0.163
- KRAS_SIGNALING_DN-0.149
- GLYCOLYSIS-0.140
- HYPOXIA-0.136
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 24 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| INTERFERON_ALPHA_RESPONSE | 0.374 | Inavolisib | — uncovered |
| MITOTIC_SPINDLE | 0.351 | Inavolisib | — uncovered |
| UV_RESPONSE_DN | 0.317 | Inavolisib | — uncovered |
| ADIPOGENESIS | 0.306 | Inavolisib | — uncovered |
| WNT_BETA_CATENIN_SIGNALING | 0.304 | Inavolisib | — uncovered |
| PEROXISOME | 0.288 | Idelalisib | — uncovered |
| PI3K_AKT_MTOR_SIGNALING | 0.265 | Inavolisib | — uncovered |
| TGF_BETA_SIGNALING | 0.216 | Inavolisib | — uncovered |
| INTERFERON_GAMMA_RESPONSE | 0.212 | Idelalisib | — uncovered |
| APICAL_SURFACE | 0.194 | Temsirolimus | — uncovered |
| ANDROGEN_RESPONSE | 0.171 | Inavolisib | — uncovered |
| PROTEIN_SECRETION | 0.163 | Remibrutinib | — uncovered |
| DNA_REPAIR | 0.152 | Idelalisib | — uncovered |
| APICAL_JUNCTION | 0.151 | Inavolisib | — uncovered |
| EPITHELIAL_MESENCHYMAL_TRANSITION | 0.147 | Inavolisib | — uncovered |
| ALLOGRAFT_REJECTION | 0.119 | Idelalisib | — uncovered |
| HEME_METABOLISM | 0.097 | Temsirolimus | — uncovered |
| UNFOLDED_PROTEIN_RESPONSE | 0.083 | Idelalisib | — uncovered |
| HEDGEHOG_SIGNALING | 0.070 | Inavolisib | — uncovered |
| BILE_ACID_METABOLISM | 0.057 | Inavolisib | — uncovered |